Sarepta Therapeutics (SRPT) Announces Publication of AVI-7288 Safety Data; No Toxicology Concerns Demonstrated
Tweet Send to a Friend
Sarepta Therapeutics (NASDAQ: SRPT) announced the publication of results from a multiple ascending dose study to determine the safety of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE